Virulence Factors of Escherichia coli Isolates That Produce CTX-M-Type Extended-Spectrum β-Lactamases
Open Access
- 1 November 2005
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (11) , 4667-4670
- https://doi.org/10.1128/aac.49.11.4667-4670.2005
Abstract
This study determined the phylogenetic groups and virulence factors of 37 Escherichia coli isolates producing types of CTX-M compared with those of 19 isolates producing different types of extended-spectrum β-lactamases (ESBLs) in a well-defined North American population. Most CTX-M-14 producers (97%) were from phylogenic group D; 67% of the CTX-M-15 producers were from group B2. A single CTX-M-14-producing strain belonged to clonal group A. There were significant prevalence differences for individual virulence factors among CTX-M producers and nonproducers; however, aggregate virulence factor scores were similar. CTX-M producers more commonly caused repeat urinary tract infections. Our results indicate that CTX-M type predicts phylogenetic background, and the virulence potential of ESBL-producing E. coli isolates is a complex issue, requiring further study and ongoing surveillance.Keywords
This publication has 34 references indexed in Scilit:
- Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patientsInternational Journal of Antimicrobial Agents, 2005
- Emergence of CTX-M-15-Producing Enterobacteria in Cameroon and Characterization of a bla CTX-M-15 -Carrying ElementAntimicrobial Agents and Chemotherapy, 2005
- First Description of CTX-M-15-Producing Klebsiella pneumoniae in PortugalAntimicrobial Agents and Chemotherapy, 2005
- Emergence and Spread of Three Clonally Related Virulent Isolates of CTX-M-15-Producing Escherichia coli with Variable Resistance to Aminoglycosides and Tetracycline in a French Geriatric HospitalAntimicrobial Agents and Chemotherapy, 2004
- Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UKJournal of Antimicrobial Chemotherapy, 2004
- Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, BulgariaClinical Microbiology & Infection, 2004
- Decreased Invasive Capacity of Quinolone‐ResistantEscherichia coliin Patients with Urinary Tract InfectionsClinical Infectious Diseases, 2001
- Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-ResistantEscherichia coliClonal GroupNew England Journal of Medicine, 2001
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Extended Virulence Genotypes ofEscherichia coliStrains from Patients with Urosepsis in Relation to Phylogeny and Host CompromiseThe Journal of Infectious Diseases, 2000